Alfred Hospital

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Prostate cancer2 trials

Phase

• Phase 11 trial
• Phase 21 trial

Status

• Active, not recruiting1 trial
• Terminated1 trial

Lead sponsor

• Peter MacCallum Cancer Centre, Australia2 trials

Running trials

• Active, not recruiting

  In Men With Metastatic Prostate Cancer, What is the Safety and Benefit of Lutetium-177 PSMA Radionuclide Treatment in Addition to Chemotherapy

  NCT04343885· Phase 2· Peter MacCallum Cancer Centre, Australia· Source

Closed trials

• Terminated

  Pidnarulex and Talazoparib in Patients With Metastatic Castration Resistant Prostate Cancer

  NCT05425862· Phase 1· Peter MacCallum Cancer Centre, Australia· Source